Literature DB >> 12643182

Microalbuminuria in diabetes: focus on cardiovascular and renal risk reduction.

George L Bakris1, James R Sowers.   

Abstract

Albuminuria has long been recognized as a harbinger for the progression of diabetic nephropathy. Recently, it has become increasingly recognized that albuminuria is a powerful risk factor for cardiovascular disease and stroke. In this article we explore evidence for albuminuria being an integral component of the cardiometabolic syndrome and a risk factor for cardiovascular disease and stroke.

Entities:  

Mesh：

Year:  2002        PMID： 12643182     DOI： 10.1007/s11892-002-0092-4

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


  33 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  S I McFarlane; M Banerji; J R Sowers
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation.

Authors:  W F Keane; G Eknoyan
Journal:  Am J Kidney Dis       Date:  1999-05       Impact factor: 8.860

Review 3.  Diabetes and cardiovascular disease.

Authors:  J R Sowers; M A Lester
Journal:  Diabetes Care       Date:  1999-04       Impact factor: 19.112

Review 4.  Microalbuminuria in essential hypertension and diabetes mellitus.

Authors:  H H Parving
Journal:  J Hypertens Suppl       Date:  1996-09

Review 5.  Diabetes, hypertension, and cardiovascular disease: an update.

Authors:  J R Sowers; M Epstein; E D Frohlich
Journal:  Hypertension       Date:  2001-04       Impact factor: 10.190

6.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

7.  Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

Authors:  G L Bakris; M R Weir
Journal:  Arch Intern Med       Date:  2000-03-13

8.  Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.

Authors:  M Marre; X Jeunemaitre; Y Gallois; M Rodier; G Chatellier; C Sert; L Dusselier; Z Kahal; L Chaillous; S Halimi; A Muller; H Sackmann; B Bauduceau; F Bled; P Passa; F Alhenc-Gelas
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

9.  Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs.

Authors:  L Gaber; C Walton; S Brown; G Bakris
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

10.  Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.

Authors:  G L Bakris; M R Weir; V DeQuattro; F G McMahon
Journal:  Kidney Int       Date:  1998-10       Impact factor: 10.612
View more
  2 in total

Review 1.  Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management.

Authors:  Fadi El-Atat; Samy I McFarlane; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

2.  Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes.

Authors:  Ayad A Jaffa; William R Usinger; M Brent McHenry; Miran A Jaffa; Stuart R Lipstiz; Daniel Lackland; Maria Lopes-Virella; Louis M Luttrell; Peter W F Wilson
Journal:  J Clin Endocrinol Metab       Date:  2008-03-04       Impact factor: 5.958
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.